We are live on ! Find out more
TEC

Tiger Eye Capital Portfolio holdings

AUM $113M
1-Year Est. Return 11.44%
This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
-11.44%
3 Year Est. Return
+116.39%
5 Year Est. Return
+328.27%
10 Year Est. Return
–
AUM
$734M
AUM Growth
-$627M
Cap. Flow
-$611M
Cap. Flow %
-83.31%
Top 10 Hldgs %
54.19%
Holding
58
New
13
Increased
8
Reduced
12
Closed
25
Avg Time Held
1.8 quarters
Top 10 Avg Time Held
0.5 quarters
Top 20 Avg Time Held
1.3 quarters

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$64.6M
2
AGN
Allergan plc
AGN
+$55.9M
3
AXTA icon
Axalta
AXTA
+$48M
4
AAPL icon
Apple
AAPL
+$44.7M
5
LBTYA icon
Liberty Global Class A
LBTYA
+$43.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.58%
2 Healthcare 21.31%
3 Industrials 18.36%
4 Communication Services 16.91%
5 Technology 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CDK
51
DELISTED
CDK Global, Inc.
CDK
– –
-784,617
Closed -$42.4M –
ZAYO
52
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-404,129
Closed -$10.4M –
RSPP
53
DELISTED
RSP Permian, Inc.
RSPP
– –
-554,084
Closed -$15.6M –
CXRX
54
DELISTED
Concordia International Corp. Common Stock
CXRX
– –
-113,500
Closed -$8.19M –
LVLT
55
DELISTED
Level 3 Communications Inc
LVLT
– –
-783,132
Closed -$41.2M –
GI
56
DELISTED
EndoChoice Holdings, Inc.
GI
– –
-80,000
Closed -$1.31M –
SHPG
57
DELISTED
Shire pic
SHPG
– –
-88,372
Closed -$21.3M –
TWC
58
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
– –
-230,100
Closed -$41M –

Similar funds

Tiger Eye Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Tiger Eye Capital held 58 positions worth $734M, down 46% from $1.36B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tiger Eye Capital withdrew a net $611M in Q3 2015, closing 25 positions and reducing 12 holdings. Its most notable exit was Bausch Health, an estimated $64.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Tiger Eye Capital opened a new position in Walgreens Boots Alliance worth $31.3M.

  • Tiger Eye Capital's largest Q3 2015 buy was Walgreens Boots Alliance: 376,698 shares worth $31.3M.
  • Tiger Eye Capital added most to Envision Healthcare Holdings Inc in Q3 2015, an estimated $22.4M increase.
  • Tiger Eye Capital's biggest Q3 2015 reduction was Allergan plc, cutting an estimated $55.9M.
  • Tiger Eye Capital fully exited Bausch Health in Q3 2015, selling an estimated $64.6M.
  • Tiger Eye Capital's ten largest holdings make up 54% of its $734M portfolio in Q3 2015.
  • Tiger Eye Capital opened 13 new positions and closed 25 in Q3 2015.
  • Tiger Eye Capital's portfolio value fell 46% quarter-over-quarter to $734M.

Based on Tiger Eye Capital's 13F filing for Q3 2015, filed 10 Nov 2015.